We are live on ! Find out more
AC

Argentiere Capital Portfolio holdings

AUM $15.4M
1-Year Est. Return 8.82%
This Fund
S&P 500
This Quarter Est. Return
-2.51%
1 Year Est. Return
-8.82%
3 Year Est. Return
+1.98%
5 Year Est. Return
+9.17%
10 Year Est. Return
AUM
$259M
AUM Growth
+$24.5M
Cap. Flow
+$269M
Cap. Flow %
104.04%
Top 10 Hldgs %
71.6%
Holding
85
New
30
Increased
14
Reduced
3
Closed
27

Sector Composition

Rank Sector Weight
1 Financials 13.25%
2 Healthcare 12.38%
3 Energy 11.99%
4 Technology 10.72%
5 Consumer Discretionary 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
76
PUT
Procter & Gamble
PG
$336B
-35,600
Closed -$296K
SPG icon
77
PUT
Simon Property Group
SPG
$74.4B
-20,000
Closed -$204K
TLT icon
78
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
-125,000
Closed -$15.2M
V icon
79
Visa
V
$684B
-12,180
Closed -$1.46M
V icon
80
PUT
Visa
V
$684B
-50,000
Closed -$360K
WDC icon
81
Western Digital
WDC
$188B
-13,230
Closed -$923K
CPAY icon
82
Corpay
CPAY
$25B
-19,400
Closed -$3.93M
AET
83
DELISTED
Aetna Inc
AET
-208,207
Closed -$35.2M
TWX
84
DELISTED
Time Warner Inc
TWX
-390,000
Closed -$36.9M
MON
85
DELISTED
Monsanto Co
MON
-170,000
Closed -$19.8M

Similar funds

Argentiere Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Argentiere Capital held 85 positions worth $259M, up 10% from $234M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Argentiere Capital deployed $269M of net new capital in Q2 2018, opening 30 new positions and adding to 14 existing holdings. Its largest new stake was SPDR Gold Trust: 675,000 shares worth $80.1M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $3.07M trimmed.

  • Argentiere Capital's largest Q2 2018 buy was SPDR Gold Trust: 675,000 shares worth $80.1M.
  • Argentiere Capital added most to NXP Semiconductors in Q2 2018, an estimated $9.92M increase.
  • Argentiere Capital's biggest Q2 2018 reduction was BioMarin Pharmaceuticals, cutting an estimated $3.07M.
  • Argentiere Capital fully exited Time Warner Inc in Q2 2018, selling an estimated $36.9M.
  • Argentiere Capital's ten largest holdings make up 72% of its $259M portfolio in Q2 2018.
  • Argentiere Capital opened 30 new positions and closed 27 in Q2 2018.
  • Argentiere Capital's portfolio value rose 10% quarter-over-quarter to $259M.

Based on Argentiere Capital's 13F filing for Q2 2018, filed 14 Aug 2018.